Theravance Biopharma, Inc.
TBPH
$9.75
$0.212.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.74% | -31.82% | -42.62% | -58.56% | -68.72% |
| Total Receivables | 291.67% | -1.24% | -9.48% | 19.51% | 4.10% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -68.65% | -22.16% | 1.99% | 23.70% | 48.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 20.61% | -27.96% | -37.86% | -52.44% | -62.22% |
|
|
|||||
| Total Current Assets | 20.61% | -27.96% | -37.86% | -52.44% | -62.22% |
| Net Property, Plant & Equipment | -21.13% | -20.79% | -16.77% | -14.08% | -12.78% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -22.54% | -1.24% | -1.87% | -2.03% | 0.58% |
| Total Assets | -7.29% | -13.90% | -18.94% | -31.05% | -37.11% |
|
|
|||||
| Total Accounts Payable | 47.11% | -38.60% | 6.69% | -36.69% | -1.93% |
| Total Accrued Expenses | 3.49% | -14.84% | -23.42% | -41.35% | -37.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 173.06% | -56.80% | -53.94% | -45.32% | -41.91% |
| Total Finance Division Other Current Liabilities | -9.82% | 26,941.67% | 26,941.67% | 26,941.67% | -- |
| Total Other Current Liabilities | -9.82% | 26,941.67% | 26,941.67% | 26,941.67% | -- |
| Total Current Liabilities | 29.55% | -7.62% | -6.52% | -17.27% | -13.75% |
|
|
|||||
| Total Current Liabilities | 29.55% | -7.62% | -6.52% | -17.27% | -13.75% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.55% | -0.81% | -0.19% | 0.18% | -0.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.51% | 5.21% | 3.57% | 2.95% | 8.22% |
| Total Liabilities | 5.69% | 1.79% | 1.12% | -0.92% | 2.06% |
|
|
|||||
| Common Stock & APIC | 1.68% | -0.99% | -3.51% | -9.69% | -13.39% |
| Retained Earnings | -6.21% | -5.49% | -5.12% | -5.11% | -6.46% |
| Treasury Stock & Other | 110.77% | 122.22% | 92.31% | -180.39% | -333.33% |
| Total Common Equity | -17.58% | -24.57% | -30.87% | -44.71% | -51.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.58% | -24.57% | -30.87% | -44.71% | -51.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.58% | -24.57% | -30.87% | -44.71% | -51.79% |
|
|
|||||